Sulphasalazine inhibits macrophage activation: Inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression

Immunology

Volumn 103, Issue 4, 2001, Pages 473-478

  Haskó, György ^a   Szabó, Csaba ^b   Németh, Zoltán H ^a   Deitch, Edwin A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b INOTEK CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESALAZINE; NITRIC OXIDE SYNTHASE; PROTEIN P40; PROTEIN P42; PROTEIN P44; SALAZOSULFAPYRIDINE; STRESS ACTIVATED PROTEIN KINASE; SULFAPYRIDINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVATION; INHIBITION KINETICS; LYMPHOCYTE; MACROPHAGE ACTIVATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CULTURE TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-12; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MESALAMINE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SULFAPYRIDINE; SULFASALAZINE; UP-REGULATION;

EID: 0034889836     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01272.x     Document Type: Article

References (33)

1. Salicylates for ulcerative colitis-their mode of action
2. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: A preventive strategy
3. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
4. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites
5. Effect of sulfasalazine on B cells
6. Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells
7. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells
8. Inhibition of cell-mediated cytotoxicity by sulphasalazine: Effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity
9. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis
10. Effects of antirheumatic agents on cytokines
11. The effect of sulfasalazine and its active components on human polymorphonuclear leucocyte function in relation to ulcerative colitis
12. Inhibition of leucocyte adhesion molecule upregulation by tumor necrosis factor α: A novel mechanism of action of sulphasalazine
13. Amelioration of chronic ileitis by nitric oxide synthase inhibition
14. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis
15. Suppression of arthritis by an inhibitor of nitric oxide synthase
16. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice
17. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock
18. Role of CSBP/p38/RK stress kinase response in LPS and cytokine signaling mechanisms
19. Signal transduction and transcription factors in rheumatic disease
20. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis
21. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice
22. Antibodies to interleukin 12 abrogate established experimental colitis in mice
23. Induced expression of class II transplantation antigens in the cartilage-pannus junction in RA chronic synovitis as a model system for aberrant T-lymphocyte activation
24. Antigen-presenting cells in rheumatoid arthritis
25. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease
26. Anti-cytokine therapy for rheumatoid arthritis
27. Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages
28. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats
29. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase
30. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice
31. Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats
32. Influence on antirheumatic drugs on nitric oxide and interleukin 8 production in human articular chondrocytes
33. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system